CO5251439A1 - Compuestos calciliticos - Google Patents
Compuestos calciliticosInfo
- Publication number
- CO5251439A1 CO5251439A1 CO00006199A CO00006199A CO5251439A1 CO 5251439 A1 CO5251439 A1 CO 5251439A1 CO 00006199 A CO00006199 A CO 00006199A CO 00006199 A CO00006199 A CO 00006199A CO 5251439 A1 CO5251439 A1 CO 5251439A1
- Authority
- CO
- Colombia
- Prior art keywords
- group
- r1and
- optionally substituted
- heterocyclic ring
- calcilitical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- AQTFKGDWFRRIHR-UHFFFAOYSA-L 3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoate;cobalt(2+);hydron Chemical compound [Co+2].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 AQTFKGDWFRRIHR-UHFFFAOYSA-L 0.000 abstract 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Un compuesto seleccionado de la formula (I) indicada a continuación: <EMI FILE="00006199_1" ID="1" IMF=JPEG >en la cual: A representa un anillo de arilo que está unido en la posición 4 ó 5, como se indica; X se selecciona del grupo constituido por CN, NO2, Cl, F y H; Y se selecciona del grupo constituido por Cl, F, Br, I y H; Q se selecciona del grupo constituido por H, R1, SO2R1, R1C(O)ORAND#391, tetrazol, CH2OH, COH, SO2NR1R1AND#39, C(O)NR1R1 AND#39, y NR1SO2R1AND#39, en cuyas fórmulas R1 y R1AND#39 se seleccionan independientemente del grupo constituido por hidrógeno, alquilo C1-4, y alquilo opcionalmente sustituido, o R1 Y R1AND#39 forman juntos un anillo heterocíclico de 3 a 7 miembros opcionalmente sustituido; y Ar es fenilo o naftilo, heteroarilo o heteroarilo condensado, sustituido o no sustituido, tal que el anillo heterocíclico puede contener N, O o S y puede ser aromático, dihidro o tetrahidro.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11824099P | 1999-02-02 | 1999-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5251439A1 true CO5251439A1 (es) | 2003-02-28 |
Family
ID=22377367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00006199A CO5251439A1 (es) | 1999-02-02 | 2000-02-02 | Compuestos calciliticos |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6417215B1 (es) |
| EP (1) | EP1148876A4 (es) |
| JP (1) | JP2002536330A (es) |
| KR (1) | KR20010093285A (es) |
| CN (1) | CN1346269A (es) |
| AP (1) | AP2001002220A0 (es) |
| AU (1) | AU3480200A (es) |
| BG (1) | BG105847A (es) |
| BR (1) | BR0007922A (es) |
| CA (1) | CA2361589A1 (es) |
| CO (1) | CO5251439A1 (es) |
| CZ (1) | CZ20012797A3 (es) |
| EA (1) | EA200100854A1 (es) |
| HK (1) | HK1042036A1 (es) |
| HU (1) | HUP0200121A3 (es) |
| ID (1) | ID29533A (es) |
| IL (1) | IL144470A0 (es) |
| MA (1) | MA25379A1 (es) |
| NO (1) | NO20013769L (es) |
| OA (1) | OA11757A (es) |
| PE (1) | PE20001456A1 (es) |
| SK (1) | SK10982001A3 (es) |
| WO (1) | WO2000045816A1 (es) |
| ZA (1) | ZA200106298B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60136187D1 (de) * | 2000-08-11 | 2008-11-27 | Japan Tobacco Inc | Calciumrezeptor-antagonisten |
| JP2004514659A (ja) * | 2000-10-25 | 2004-05-20 | スミスクライン・ビーチャム・コーポレイション | カルシライティック化合物 |
| US6864267B2 (en) * | 2001-07-16 | 2005-03-08 | Smithkline Beecham Corporation | Calcilytic compounds |
| MY143244A (en) * | 2002-11-26 | 2011-04-15 | Smithkline Beecham Corp | Calcilytic compounds |
| WO2004069793A2 (en) | 2003-01-28 | 2004-08-19 | Bristol-Myers Squibb Company | Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| US7205322B2 (en) | 2003-02-12 | 2007-04-17 | Bristol-Myers Squibb Company | Thiazolidine compounds as calcium sensing receptor modulators |
| PT1619180E (pt) | 2003-04-23 | 2009-12-29 | Japan Tobacco Inc | Antagonista de casr |
| JPWO2004106280A1 (ja) | 2003-05-28 | 2006-07-20 | 日本たばこ産業株式会社 | ＣａＳＲアンタゴニスト |
| US7265145B2 (en) | 2003-05-28 | 2007-09-04 | Bristol-Myers Squibb Company | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method |
| EP1964548A1 (en) * | 2007-03-02 | 2008-09-03 | Novartis AG | Pharmaceutical compositions comprising a calcilytic agent |
| EP2292592B1 (en) * | 2008-06-05 | 2012-09-05 | Asahi Kasei Pharma Corporation | Sulfonamide compound and application thereof |
| WO2010103429A1 (en) | 2009-03-10 | 2010-09-16 | Pfizer Inc. | 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists |
| GB201217330D0 (en) * | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
| WO2021029517A1 (en) * | 2019-08-13 | 2021-02-18 | Dongguk University Industry-Academic Cooperation Foundation | Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122010000024I1 (de) | 1990-02-19 | 2010-07-08 | Novartis Ag | Acylverbindungen |
| DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| EA002984B1 (ru) * | 1996-04-09 | 2002-12-26 | Эн Пи Эс Фармасьютикалз, Инк. | Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений |
| UY24949A1 (es) * | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
-
2000
- 2000-02-01 PE PE2000000070A patent/PE20001456A1/es not_active Application Discontinuation
- 2000-02-02 US US09/890,310 patent/US6417215B1/en not_active Expired - Lifetime
- 2000-02-02 EP EP00913335A patent/EP1148876A4/en not_active Withdrawn
- 2000-02-02 IL IL14447000A patent/IL144470A0/xx unknown
- 2000-02-02 ID IDW00200101673A patent/ID29533A/id unknown
- 2000-02-02 KR KR1020017009467A patent/KR20010093285A/ko not_active Withdrawn
- 2000-02-02 CO CO00006199A patent/CO5251439A1/es unknown
- 2000-02-02 AP APAP/P/2001/002220A patent/AP2001002220A0/en unknown
- 2000-02-02 OA OA1200100199A patent/OA11757A/en unknown
- 2000-02-02 CN CN00805996A patent/CN1346269A/zh active Pending
- 2000-02-02 AU AU34802/00A patent/AU3480200A/en not_active Abandoned
- 2000-02-02 EA EA200100854A patent/EA200100854A1/ru unknown
- 2000-02-02 HU HU0200121A patent/HUP0200121A3/hu unknown
- 2000-02-02 CZ CZ20012797A patent/CZ20012797A3/cs unknown
- 2000-02-02 SK SK1098-2001A patent/SK10982001A3/sk unknown
- 2000-02-02 WO PCT/US2000/002676 patent/WO2000045816A1/en not_active Ceased
- 2000-02-02 BR BR0007922-7A patent/BR0007922A/pt not_active IP Right Cessation
- 2000-02-02 CA CA002361589A patent/CA2361589A1/en not_active Abandoned
- 2000-02-02 JP JP2000596936A patent/JP2002536330A/ja not_active Withdrawn
- 2000-02-02 HK HK02101521.4A patent/HK1042036A1/zh unknown
-
2001
- 2001-07-31 ZA ZA200106298A patent/ZA200106298B/en unknown
- 2001-08-01 MA MA26283A patent/MA25379A1/fr unknown
- 2001-08-01 NO NO20013769A patent/NO20013769L/no not_active Application Discontinuation
- 2001-08-27 BG BG105847A patent/BG105847A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1346269A (zh) | 2002-04-24 |
| OA11757A (en) | 2005-07-19 |
| EP1148876A4 (en) | 2003-07-23 |
| SK10982001A3 (sk) | 2001-12-03 |
| WO2000045816A1 (en) | 2000-08-10 |
| NO20013769L (no) | 2001-09-26 |
| EP1148876A1 (en) | 2001-10-31 |
| EA200100854A1 (ru) | 2002-02-28 |
| IL144470A0 (en) | 2002-05-23 |
| ID29533A (id) | 2001-09-06 |
| AU3480200A (en) | 2000-08-25 |
| KR20010093285A (ko) | 2001-10-27 |
| HUP0200121A3 (en) | 2002-11-28 |
| PE20001456A1 (es) | 2001-01-28 |
| BR0007922A (pt) | 2001-11-06 |
| CA2361589A1 (en) | 2000-08-10 |
| JP2002536330A (ja) | 2002-10-29 |
| MA25379A1 (fr) | 2002-04-01 |
| ZA200106298B (en) | 2002-10-18 |
| US6417215B1 (en) | 2002-07-09 |
| CZ20012797A3 (cs) | 2002-01-16 |
| AP2001002220A0 (en) | 2001-09-30 |
| NO20013769D0 (no) | 2001-08-01 |
| BG105847A (en) | 2002-04-30 |
| HUP0200121A2 (hu) | 2002-05-29 |
| HK1042036A1 (zh) | 2002-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5251439A1 (es) | Compuestos calciliticos | |
| PT1140851E (pt) | 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais | |
| CO5271690A1 (es) | Derivados de pirimidina | |
| CO5060482A1 (es) | Derivados terapeuticos de biarilo | |
| CO5320599A1 (es) | Inhibidores no peptidilicos de la union a las celulas depen dientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| CO5200785A1 (es) | Uso terapeutico de quinazolina | |
| CO5080780A1 (es) | Derivado de amida y antagonista de nociceptina | |
| CO5460265A1 (es) | Compuestos quimicos | |
| EA200000096A1 (ru) | Производные арилоксиарилсульфониламиногидроксамовой кислоты | |
| CO5150164A1 (es) | Derivados de pirazolopiridina | |
| DK1140916T3 (da) | Heteroaryl-cykliske acetaler | |
| ES2173846T3 (es) | Compuestos de biciclocarbonil indol como agentes antiinflamatorios/analgesicos y como inhibidores de cox-2. | |
| DE60005504D1 (de) | Chinolinderivate als mek enzym-inhibitoren | |
| DE60226875D1 (de) | Orthosubstituierte arylamide zur bekämpfung von wirbellosen schädlingen | |
| CA2286723A1 (en) | Tricyclic compounds | |
| DE69005164D1 (de) | Acryloylsubstituierte Pyrrol-Derivate. | |
| ES2178451T3 (es) | Derivados de benzoxadiazoles, benzotiadiazoles, benzotriazoles y quinoxalinas. | |
| PE20010327A1 (es) | Derivados de aminopirrolidina heterociclica como agentes melatonergicos | |
| CO5210890A1 (es) | Compuestos quimicos del tipo benzodia - o tiazoles y su proceso de obtencion | |
| CO5261594A1 (es) | Inhibidores de myt1 cinasa | |
| ECSP045309A (es) | Derivados de fenil amidas con silicio útiles como microbiocidas | |
| ATE126798T1 (de) | Chinoline derivate, nützlich als angiotensin-ii- antagonisten. | |
| CO5200762A1 (es) | Preparacion de piperidin-4-onas sustituidas | |
| CO5140099A1 (es) | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores | |
| CO5160255A1 (es) | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN |